Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.

Einarson A, Pistelli A, DeSantis M, Malm H, Paulus WD, Panchaud A, Kennedy D, Einarson TR, Koren G.

Am J Psychiatry. 2008 Jun;165(6):749-52. doi: 10.1176/appi.ajp.2007.07060879. Erratum in: Am J Psychiatry. 2008 Sep;165(9):1208. Am J Psychiatry. 2008 Jun;165(6):777.

PMID:
18381907
2.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
3.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
4.
5.

Paroxetine in the first trimester and the prevalence of congenital malformations.

Cole JA, Ephross SA, Cosmatos IS, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1075-85.

PMID:
17729379
6.

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study..

N Engl J Med. 2007 Jun 28;356(26):2684-92.

7.

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT.

Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100. doi: 10.1002/bdra.20641.

PMID:
19937603
8.
9.

[SSRIs and pregnancy: a review of the literature].

Soufia M, Aoun J, Gorsane MA, Krebs MO.

Encephale. 2010 Dec;36(6):513-6. doi: 10.1016/j.encep.2010.02.003. Review. French.

PMID:
21130237
10.

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Källén BA, Otterblad Olausson P.

Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8.

PMID:
17216624
11.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
12.

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Wurst KE, Poole C, Ephross SA, Olshan AF.

Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70. doi: 10.1002/bdra.20627.

PMID:
19739149
13.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
14.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
15.

Bupropion in pregnancy and the prevalence of congenital malformations.

Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):474-84.

PMID:
16897811
16.

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.

Br J Clin Pharmacol. 2008 Nov;66(5):695-705. doi: 10.1111/j.1365-2125.2008.03261.x.

17.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics..

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
18.

Reported multivitamin consumption and the occurrence of multiple congenital anomalies.

Yuskiv N, Honein MA, Moore CA.

Am J Med Genet A. 2005 Jul 1;136(1):1-7.

PMID:
15937944
19.

Maternal use of antipsychotics in early pregnancy and delivery outcome.

Reis M, Källén B.

J Clin Psychopharmacol. 2008 Jun;28(3):279-88. doi: 10.1097/JCP.0b013e318172b8d5.

PMID:
18480684
20.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA.

N Engl J Med. 2006 Jun 8;354(23):2443-51.

Items per page

Supplemental Content

Support Center